BOARD OF DIRECTORS

Richard C. Boucher, MD
Dr. Boucher is currently the James Moeser Eminent Professor of Medicine, Director of the Marsico Lung Institute and the UNC CF Center at the University of North Carolina at Chapel Hill. Dr. Boucher is also Co-Chairman and Founder of Parion Sciences. Dr. Boucher is a world renowned expert in the area of airway epithelia and related diseases including Cystic Fibrosis. Ric has 500 scientific publications and over 30 issued patents and has founded multiple companies including Inspire Pharmaceuticals and Parion Sciences. He serves as an editor of numerous scientific publications and as has served as advisor for several organizations.Dr. Boucher earned his undergraduate degree from Yale University and completed his Medical Degree and Residency at Columbia University and Columbia Presbyterian Hospital. He was a Research Fellow at McGill University and completed a Residency and Fellowship at Royal Victoria Hospital in Montreal Canada.

Robert Wills, PhD
Dr. Robert Wills has over three decades of experience as a leader in the pharmaceutical industry. Dr. Wills currently serves as the Executive Chairman of GTx, Inc, Chairman of the Board of CymaBay Therapeutics, and a member of the Emerging Companies Section Governing Board of Biotechnology Innovation Organization (BIO). Prior to these roles, Dr Wills spent over 25 years at Johnson & Johnson. Most recently he was Vice President, Alliance Management, Janssen Pharmaceutical Companies of Johnson & Johnson. He also served as Senior Vice President Global Development, where he was responsible for the R&D pipeline and a member of the R&D Board of Directors. In addition he served on several of the commercial Operating Company Boards and key pharmaceutical group decision-making committees. Dr Wills began his career at Hoffmann-LaRoche where he spent 10 years in several roles of scientific responsibility. Dr Wills holds a B.S. in Biochemistry and an M.S. in Pharmaceutics from the University of Wisconsin and a Ph.D. in Pharmaceutics from the University of Texas.

Paul Boucher, MBA, President & CEO
Paul Boucher is the President and Chief Executive Officer of Parion Sciences and responsible for leading our senior management team and organization as we continue to advance our innovative pipeline products. Mr. Boucher joined Parion in 2006 and previously served as President as well as Vice-President of Finance and Business where he led business development, operations, finance and alliance management.Mr. Boucher has over 15 years of strategic planning, financial operations, negotiations and corporate leadership experience. Prior to joining Parion, Paul served in a corporate account leadership role at Colliers-Seely and consulted with Fortune 500 companies on their corporate real estate strategy and transaction management. Prior to Colliers-Seely, Mr. Boucher held several leadership positions at Toyota Motor Company in the areas of finance, real estate, strategic planning, and marketing. Paul also held a strategic planning role at Bristol-Myers-Squibb. Mr. Boucher holds a B.S. in Civil Engineering from Rensselaer Polytechnic Institute and an M.B.A. from Kenan Flagler Business School. Mr. Boucher serves as a board member for the Carolina’s Chapter of the Cystic Fibrosis Foundation and as an advisory board member for the Professional Science Masters Program at the University of North Carolina, Chapel Hill. He has served as a guest lecturer at The University of North Carolina.